Comparison Between Maternal Complications of Chromic Catgut and Vicryl Rapid Sutures Used for Episiotomy Repair
1 other identifier
interventional
202
1 country
1
Brief Summary
Total 202 patients fulfilling the selection criteria were enrolled from labor room and underwent episiotomy. At end of procedure, females were randomly divided in two groups. In group A, females underwent suturing by using vicryl rapide. In group B, females underwent suturing by using chromic catgut. After 24 hours of delivery, females were examined for pain score. After 7 days, females were examined for wound infection, inflammation and dehiscence. All this information was recorded in proforma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFirst Submitted
Initial submission to the registry
July 9, 2025
CompletedFirst Posted
Study publicly available on registry
July 18, 2025
CompletedJuly 18, 2025
July 1, 2025
6 months
July 9, 2025
July 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Wound dehiscence
Wound dehiscence was labeled if there was partial or total separation of previously approximated wound edges, due to a failure of proper wound healing within 7 days of episiotomy.
7 days
Post surgical pain
After 24 hours of episiotomy participants were examined for pain score by using visual analogue scale.
7 days
Wound Infection
Wound infection was labeled if participant developed pain and pus discharge at wound site, along with fever (\>100F) within 7 days of episiotomy.
7 days
Study Arms (2)
Participants with Vicryl Rapide suturing
ACTIVE COMPARATORAfter approval from ethical review board (ERC letter no: 37-2024 dated 10-01-2024), 202 females fulfilling the selection criteria were enrolled from labor room. Informed consent was taken. Demographics were noted. Then participants underwent episiotomy. At end of procedure, they were randomly divided in two groups by using lottery method. Group A includes 101 participants that underwent suturing by using vicryl rapide. After 24 hours they were examined for pain score by using visual analogue scale. They were discharged after examining the episiotomy wound and were followed-up for 7 days in OPD. During follow-up, participants were examined for pain score, wound infection, inflammation and dehiscence.
Participants with chromic catgut suturing
ACTIVE COMPARATORTotal 202 females fulfilling the selection criteria were enrolled from labor room. Informed consent was taken. Demographics were noted. Then participants underwent episiotomy. At end of procedure, they were randomly divided in two groups by using lottery method. Group B included 101 participants that underwent suturing by using chromic catgut. After 24 hours they were examined for pain score by using visual analogue scale. They were discharged after examining the episiotomy wound and were followed-up for 7 days in OPD. During follow-up, participants were examined for pain score, wound infection, inflammation and dehiscence.
Interventions
Post episiotomy vicryl rapide suturing material is used for stitching episiotomy laceration.
Post episiotomy chromic catgut suturing material is used for stitching episiotomy laceration
Eligibility Criteria
You may qualify if:
- Primigravida of age 18-35 years
- Gestational age during 37-40 weeks
You may not qualify if:
- Females with abnormal placenta, non-cephalic presentation, multiple fetus, premature rupture of membranes, unclean vaginal examination.
- pre-delivery hemoglobin \<9 g/dl,
- Manual removal of placenta
- Vulvar hematoma and vaginal tears
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Huma Ijazlead
Study Sites (1)
CMH Gujranwala
Gujranwala, Punjab Province, 52230, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr Huma Ijaz
Study Record Dates
First Submitted
July 9, 2025
First Posted
July 18, 2025
Study Start
July 1, 2024
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
July 18, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share